Has the market completely misread this, or were expectations that much higher. From earlier data, I'd say 60% reduction in mortality seems in line? Is the convoluted working in the release confusing? And why wasn't mortality the main end-point?
- Forums
- ASX - By Stock
- Ann: Mesoblast Phase 3 Chronic Heart Failure Results
Has the market completely misread this, or were expectations...
-
- There are more pages in this discussion • 855 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.41 |
Change
-0.035(2.43%) |
Mkt cap ! $1.627B |
Open | High | Low | Value | Volume |
$1.44 | $1.46 | $1.40 | $1.198M | 840.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 55208 | $1.41 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.41 | 3854 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 7561 | 1.410 |
12 | 81810 | 1.405 |
22 | 135933 | 1.400 |
9 | 124315 | 1.395 |
9 | 49383 | 1.390 |
Price($) | Vol. | No. |
---|---|---|
1.415 | 8940 | 8 |
1.420 | 21757 | 7 |
1.425 | 37965 | 7 |
1.430 | 180208 | 10 |
1.435 | 92090 | 5 |
Last trade - 11.31am 15/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online